Missouri HB2972 modifies the administration of erythromycin eye drops to newborn infants, requiring informed consent from parents or legal guardians.
Missouri HB2972 modifies provisions relating to the administration of erythromycin eye drops to newborn infants. The bill mandates that physicians, midwives, or nurses must obtain informed consent from the infant's parent or legal guardian before administering the eye drops. It prohibits these healthcare providers from administering the drops without such consent. The bill also requires a written report and documentation of the informed consent to be provided to the local public health agency within 48 hours.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.